Betadex sulfobutylether sodium — a key enabler for potent neurotherapeutics
In the search for better therapies for neurodegenerative diseases like Parkinson’s, researchers are increasingly looking beyond classical drugs to the
Tag: Parkinson's disease
Cyclodextrins as Active Therapeutic Agents: Beyond Their Role as Excipients
Cyclodextrins (CDs) have traditionally been recognized as excipients that enhance solubility and stability of drugs. However, growing evidence shows that
Restoring autophagic function: a case for type 2 diabetes mellitus drug repurposing in Parkinson’s disease
This noticable mini review was published in the last year but worth not to overlook as it is in line
The role of gut in Parkinson’s disease
The role of gut in development of Parkinson’s disease has been long suspected as constipation appears years before the typical
More and more manipulated results in Alzheimer and Parkinson’s research
„Short road to discovery, winding road to use” Josef Pitha I assume that many of you remember the “story”
Patent application: gamma-cyclodextrin-based polymer for prevention or treatment of cholesterol metabolism-related diseases
RENATUS, a South Korea-based pharma company pioneering next generation cyclodextrin-based therapies for the safe treatment of cholesterol-associated diseases recently filed